Capstone Investment Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-162,100
Closed -$2.52M 1665
2020
Q3
$2.52M Buy
+162,100
New +$2.79M 0.01% 732
2019
Q4
Sell
-45,300
Closed -$990K 1383
2019
Q3
$990K Sell
45,300
-71,500
-61% -$1.64M 0.01% 947
2019
Q2
$2.95M Buy
+116,800
New +$2.77M 0.02% 631
2018
Q1
Sell
-10,000
Closed -$207K 356
2017
Q4
$207K Buy
+10,000
New +$159K 0.01% 433
2016
Q2
Sell
-20,000
Closed -$526K 692
2016
Q1
$526K Buy
+20,000
New +$1.48M 0.02% 418
2014
Q2
Sell
-45,300
Closed -$5.97M 403
2014
Q1
$5.97M Buy
+45,300
New +$6.19M 0.08% 149

Other funds holding BHC

Capstone Investment Advisors's BHC Position: Q1 2026 in Review

Capstone Investment Advisors reduced its Bausch Health (BHC) stake by 2.4% in Q1 2026, selling an estimated $13.5K and leaving 91,216 shares worth $493K. The position accounts for ﹤0.01% of the portfolio, ranked #1145.

Capstone Investment Advisors first reported a position in BHC in Q1 2014 and has held it in 19 quarters since. The position peaked at $2.64M in Q1 2014. 228 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Capstone Investment Advisors held 91,216 shares of Bausch Health worth $493K as of Q1 2026.
  • Capstone Investment Advisors sold 2,253 Bausch Health shares in Q1 2026, an estimated $13.5K.
  • Bausch Health made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1145 holding.
  • Capstone Investment Advisors first reported a position in Bausch Health in Q1 2014 and has held it in 19 quarters since.
  • Capstone Investment Advisors's Bausch Health position peaked at $2.64M in Q1 2014.
  • 228 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.